Please login to the form below

Not currently logged in
Email:
Password:

New accounts: November - PR & Med Ed

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2006 inclusive

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

Cephalon

Targretin

Oncology

LeapFrog Medical

MSD

Univads website

N/A

LeapFrog Medical

Novo Nordisk

Healthspan range

Vitamins and minerals

Spink Consumer Relations

Reckitt Benckiser (global)

Nurofen

Pain

Virgo Health PR

Roche Products UK

Bondronat

Endocrine

Just::

Solvay

Creon

Cystic fibrosis

LeapFrog Medical

Takeda Europe

Actos

Type II diabetes

The Remedy, Fleishman-Hillard

Takeda Europe

Blopress

Hypertension

The Remedy, Fleishman-Hillard

Takeda Europe

Prostap SR

Prostate cancer

The Remedy, Fleishman-Hillard

Takeda Europe

Rozerem

Insomnia

The Remedy, Fleishman-Hillard

Takeda Europe

International medical meetings

N/A

The Remedy, Fleishman-Hillard

2nd September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics